CoQ10 100 mg

CoQ10 100 mg

SR Sports Research4.7 (2,319 ratings)
Format:Softgel Quantity: 120 Softgel(s) · 120 servings
Goals
$28.97 $0.24 per serving

Product analysis

73 out of 100

CoQ10 100 mg offers favorable value for CoQ10, with limited support for blood-vessel function and fatigue in selected groups.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

Ubiquinone is identified clearly, allowing comparison with ordinary CoQ10 preparations. The available detail does not establish an absorption or quality advantage for the combined formula.

Ingredient Transparency100

Both ingredient amounts and forms are disclosed. That makes the preparation easier to identify when comparing CoQ10 supplements.

Value For Money88

The cost for the CoQ10 amount offers favorable value. The added black pepper has no clear separate value conclusion.

Customer Satisfaction86

Customer ratings are strongly positive. The large review base gives a broader picture of customer satisfaction.

Product Focus70

CoQ10 provides the main connection to blood-vessel function and energy-related roles, with benefits dependent on the population and preparation. Black pepper does not establish extra cardiovascular or fatigue benefits.

Format
Softgel
Container
120 Softgel(s)
Per serving
$0.24
Customer rating
4.7 · 2,319 ratings
Report analysis

Goals

Longevity
Impact
Moderate effect
B- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 at 100 mg relates to mitochondrial energy production and antioxidant defence. The supplied human evidence concerns limited skin-appearance outcomes with a particular preparation; the saved assessment does not match this preparation to those trials. Piperine may affect CoQ10 absorption, which is separate from evidence of longer life.

How this product is rated for Longevity

Ingredient fit73

The assessed ingredient is closely focused on the goal, although it is also linked to other uses. The assessed amounts provide partial dose support.
Goal fit
The assessed ingredient is closely focused on the goal, although it is also linked to other uses.
Dose adequacy
The assessed amounts provide partial dose support.

Pathways10

The strongest assessed connection is mitochondrial energy production, with limited coverage. No assessed pathway reaches the saved threshold for substantial coverage.
Depth
The strongest assessed connection is mitochondrial energy production, with limited coverage.
Breadth
No assessed pathway reaches the saved threshold for substantial coverage.

Evidence30

Coenzyme Q-10 provides the strongest effective-dose evidence in the saved findings; this does not translate into a lifespan benefit. The assessed preparation is not matched to the reviewed trials in the saved findings.
Evidence strength
Coenzyme Q-10 provides the strongest effective-dose evidence in the saved findings; this does not translate into a lifespan benefit.
Studied preparation
The assessed preparation is not matched to the reviewed trials in the saved findings.

Formulation logic100

The assessed ingredients can contribute alone or have their required partner. No configured ingredient conflict was identified. 1 of 1 assessed ingredients reach the saved minimum dose threshold.
Partner coverage
The assessed ingredients can contribute alone or have their required partner.
Conflicts
No configured ingredient conflict was identified.
Effective doses
1 of 1 assessed ingredients reach the saved minimum dose threshold.
Study evidence
Cardiovascular Support
Impact
Highest effect
A- Ingredient FitD+ PathwaysA- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q-10 has limited support for blood-pressure, lipid and blood-vessel-function markers in selected people with dyslipidemia. This product supplies 100 mg ubiquinone per selected serving, giving a partial amount contribution against the saved preparation reference. Marker improvements do not establish prevention of cardiovascular events. The supplied information does not demonstrate additional cardiovascular benefit from the black pepper ingredient.

How this product is rated for Cardiovascular Support

Ingredient fit86

Coenzyme Q-10 provides the relevant ingredient focus, with partial amount support in the saved comparison.
Goal fit
Coenzyme Q-10 supplies the cardiovascular-related ingredient focus.
Dose adequacy
The saved result gives partial amount support; a serving does not establish the daily exposure or duration used in studies.

Pathways53

The strongest represented aspect is endothelial nitric-oxide function. Support is concentrated in one represented cardiovascular aspect, with other areas receiving little or no coverage.
Depth
The strongest represented aspect is endothelial nitric-oxide function, based on coenzyme q-10.
Breadth
Support is concentrated in one represented cardiovascular aspect, with other areas receiving little or no coverage.

Evidence88

Coenzyme Q-10 findings concern selected vascular, blood-pressure or lipid markers, not established event prevention.
Evidence strength
Coenzyme Q-10 findings concern selected vascular, blood-pressure or lipid markers, not established event prevention.
Studied preparation
The saved preparation check accepts the relevant forms; that does not establish identical populations, duration or clinical outcomes.

Formulation logic100

The saved result identifies no missing required partner; this does not establish extra benefit from combining ingredients. No configured ingredient conflict was identified in the supplied facts.
Partner coverage
The saved result identifies no missing required partner; this does not establish extra benefit from combining ingredients.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
The retained ingredients pass the saved minimum-amount check, which is not proof of clinical effectiveness.
Study evidence
Heart Health
Impact
Highest effect
A- Ingredient FitD+ PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 has limited support for blood-vessel function and selected blood-pressure measures in adult studies. The declared ubiquinone allows comparison with ordinary oral CoQ10 evidence. These findings do not establish general prevention of cardiovascular events, and one serving does not automatically reproduce a study’s daily exposure or duration.

How this product is rated for Heart Health

Ingredient fit86

Coenzyme Q-10 provide the included contribution, with partial coverage of the comparison amounts.
Goal fit
Coenzyme Q-10 provide the relevant focus, while the product is also linked to other goals.
Dose adequacy
The included amounts partly cover the saved comparison ranges, which describe exposure rather than proven treatment doses.

Pathways53

The strongest recorded connection is endothelial nitric-oxide function, with partial coverage of the comparison range.
Depth
The strongest recorded connection is endothelial nitric-oxide function, with partial coverage of the comparison range.
Breadth
Endothelial nitric-oxide function reached the coverage threshold; the remaining configured pathways did not.

Evidence98

Coenzyme Q-10 provides the strongest included evidence, within the limits of its studied outcomes and populations.
Evidence strength
Coenzyme Q-10 provides the strongest included evidence, within the limits of its studied outcomes and populations.
Studied preparation
The included preparations were matched to studied material, within the limits of the outcomes and populations studied.

Formulation logic100

No configured ingredient conflict was identified. The included ingredients can stand alone or have their required partner present.
Partner coverage
The included ingredients can stand alone or have their required partner present.
Conflicts
No configured ingredient conflict was identified.
Effective doses
All included ingredients clear the saved minimum amount threshold; this does not guarantee a noticeable clinical benefit.
Study evidence
Energy
Impact
High effect
B- Ingredient FitF PathwaysB+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 supports cellular energy production, with limited evidence for fatigue relief that depends on the preparation and population studied. Clinical-cohort findings do not establish routine energy benefits in healthy adults. Its included serving receives amount support, without proving an absorption advantage or a guaranteed response. Black pepper is included as a partner rather than a standalone energy ingredient.

How this product is rated for Energy

Ingredient fit73

The relevant included ingredients are Coenzyme Q-10. Their amounts receive different levels of support in the supplied findings.
Goal fit
The relevant ingredients dominate the assessed formulation, although the product is also linked to other goals.
Dose adequacy
The included amounts provide partial support against the saved amount references, without defining proven fatigue-treatment doses.

Pathways17

The supplied findings concentrate on cellular energy production. They do not establish broad coverage across the other configured energy pathways.
Depth
The best-represented configured pathway is cellular energy production.
Breadth
No configured pathway reaches the saved breadth requirement.

Evidence84

The strongest included evidence contribution comes from Coenzyme Q-10. Preparation matching does not remove the ingredient-specific limits on fatigue benefits.
Evidence strength
Coenzyme Q-10 provides the strongest included evidence contribution, subject to its specific population and deficiency limitations.
Studied preparation
The included preparations meet the saved study check, without establishing that the finished product itself was tested.

Formulation logic100

The counted ingredients meet the minimum amount requirement, without a missing required partner or matched conflict.
Partner coverage
No included ingredient lacks a required partner in the supplied findings; this does not imply extra benefit from combining ingredients.
Conflicts
No configured ingredient conflict was matched in the supplied facts.
Effective doses
All counted ingredients meet the saved minimum amount requirement, which is distinct from a proven fatigue-treatment dose.
Study evidence
Inflammation
Impact
High effect
C+ Ingredient FitF PathwaysA EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 as ubiquinone has limited relevance to inflammatory markers, based on a trial in people with coronary artery disease taking statins. The selected serving supplies 100 mg, below the 300 mg daily study exposure, so it does not establish the same effect. Black pepper does not establish an additional anti-inflammatory contribution here.

How this product is rated for Inflammation

Ingredient fit66

Coenzyme Q-10 receive recognition in the saved findings. The clinical relevance depends on the supplied nutrient-status and study-context limitations.
Goal fit
The relevant ingredient is the main focus of this formula, although it is also linked to other goals.
Dose adequacy
The declared amounts only partly match the supplied comparison references; lower amounts do not establish proportionate clinical effects.

Pathways13

The saved findings concentrate on oxidative and mitochondrial stress, with limited coverage. No pathway reaches the saved coverage threshold.
Depth
The saved findings concentrate on oxidative and mitochondrial stress, with limited coverage.
Breadth
No pathway reaches the saved coverage threshold.

Evidence93

Coenzyme Q-10 leads the saved evidence findings. The ingredient-specific population and biomarker limitations still apply.
Evidence strength
Coenzyme Q-10 provides the strongest saved evidence contribution; the supplied findings remain limited by population, biomarkers or nutrient status.
Studied preparation
The saved result recognizes the counted preparations as studied; this does not extend their findings beyond the supplied populations and outcomes.

Formulation logic100

The saved findings identify no configured conflicts or missing required partners. The counted ingredients reach the saved minimum amount threshold.
Partner coverage
The counted ingredients can contribute independently or have their required partner; no added benefit from combining them is established.
Conflicts
No configured ingredient conflict was identified in the saved findings.
Effective doses
The counted ingredients clear the saved minimum amount threshold, which is a comparison convention rather than a proven effective dose.
Study evidence
Metabolism Support
Impact
High effect
B- Ingredient FitF PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 participates in mitochondrial energy production. This normal cellular role and findings on metabolic biomarkers do not establish that taking it increases whole-body calorie expenditure.

How this product is rated for Metabolism Support

Ingredient fit73

The assessed relevant ingredients account for the formula’s actives, with broader uses beyond this goal. Retained amounts partly cover the comparison anchors, which are not proven effective doses for a lasting metabolic boost.
Goal fit
The assessed relevant ingredients account for the formula’s actives, with broader uses beyond this goal.
Dose adequacy
Retained amounts partly cover the comparison anchors, which are not proven effective doses for a lasting metabolic boost.

Pathways17

Mitochondrial energy and fat oxidation is the strongest recorded area; this does not establish a lasting increase in calorie expenditure.
Depth
Mitochondrial energy and fat oxidation is the strongest recorded area; this does not establish a lasting increase in calorie expenditure.
Breadth
None of the evaluated mechanisms reached the coverage threshold.

Evidence75

Coenzyme Q-10 leads the eligible evidence findings; its specific study population and outcomes limit expectations of a general metabolism boost.
Evidence strength
Coenzyme Q-10 leads the eligible evidence findings; its specific study population and outcomes limit expectations of a general metabolism boost.
Studied preparation
Eligible preparations match the supplied comparisons; a match does not establish lasting metabolic benefit.

Formulation logic100

No configured ingredient conflict was found. All retained ingredients meet the minimum comparison threshold; that threshold is not a proven effective dose for increasing calorie expenditure.
Partner coverage
The retained ingredients have no unmet partner requirement in the supplied findings.
Conflicts
No configured ingredient conflict was found.
Effective doses
All retained ingredients meet the minimum comparison threshold; that threshold is not a proven effective dose for increasing calorie expenditure.
Study evidence

Ingredients

IngredientAmount per servingScore
CoEnzyme Q10 (Ubiquinone)
100 mg 79
Bioperine (Black Pepper Fruit Extract)
5 mg
Gluten Free Adults 18–50 Vegan Dairy Free Vegetarian
Report overview
C Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyA+ Value
Each serving lists 100 mg of CoQ10 as ubiquinone. The whole-product price is about $0.24 per serving.
How this ingredient is rated

Active Ingredient Quality & Bioavailability64

The CoQ10 form is identified as ubiquinone. The evaluation identifies a black pepper extract or BioPerine enhancer; the saved facts do not distinguish which.
Molecular Form: Ubiquinol vs. Ubiquinone
The CoQ10 form is identified as ubiquinone.
Formulation & Absorption Enhancers
The evaluation identifies a black pepper extract or BioPerine enhancer; the saved facts do not distinguish which.

Dose, Safety & Label Transparency83

Each serving lists 100 mg of CoQ10. The amount is individually disclosed.
Clinical Dosage Alignment
The listed amount is 100 mg of CoQ10 per serving.
Label Transparency & Fillers
The amount is disclosed, and the evaluation does not flag the specified additives or standard fillers.

Value100

The whole-product price works out to about $0.24 per 100 mg of CoQ10, a relatively low rate for ubiquinone in the evaluation.
Price Per Effective Serving
The whole-product price works out to about $0.24 per 100 mg of CoQ10, a relatively low rate for ubiquinone in the evaluation.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  2. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  4. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  5. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  6. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  7. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  8. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10
  9. Antifatigue effects of coenzyme Q10 during physical fatigue.
    Mizuno K; Tanaka M; Nozaki S; Mizuma H; Ataka S; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2008
    Randomized trial17 participantsEnergy forCoenzyme Q-10
  10. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
    Mehrabani S; Askari G; Miraghajani M; Tavakoly R; Arab A · Complementary therapies in medicine · 2019
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  11. Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
    Sabbatinelli J; Orlando P; Galeazzi R; Silvestri S; Cirilli I; Marcheggiani F; Dludla PV; Giuliani A; Bonfigli AR; Mazzanti L; Olivieri F; Antonicelli R; Tiano L · Nutrients · 2021
    Randomized trial51 participantsHeart Health forCoenzyme Q-10
  12. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhao D; Liang Y; Dai S; Hou S; Liu Z; Liu M; Dong X; Zhan Y; Tian Z; Yang Y · Advances in nutrition (Bethesda, Md.) · 2022
    Meta-analysis1,831 participants26 studies pooledHeart Health forCoenzyme Q-10
  13. Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Zhang Z; Liu Z; Geng Y; Huang Y; Hu R; Li F; Song Y; Zhang M · Journal of diabetes research · 2026
    Meta-analysis3,422 participants64 studies pooledHeart Health Metabolism Support forCoenzyme Q-10
  14. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W · Journal of clinical lipidology · 2019
    Randomized trial101 participantsHeart Health forCoenzyme Q-10
  15. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2021
    Randomized trial43 participantsInflammation forCoenzyme Q-10
  16. The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
    Karamali M; Gholizadeh M · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2022
    Randomized trial55 participantsInflammation forCoenzyme Q-10
  17. Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
    Hou S; Tian Z; Zhao D; Liang Y; Dai S; Ji Q; Fan Z; Liu Z; Liu M; Yang Y · Molecular nutrition & food research · 2023
    Meta-analysis1,517 participants31 studies pooledInflammation forCoenzyme Q-10
  18. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
    Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M · Pharmacological research · 2020
    Meta-analysis509 participants9 studies pooledInflammation forCoenzyme Q-10
  19. Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
    Elsherif N; Shousha G; Sabri NA; Shawki MA · Immunopharmacology and immunotoxicology · 2026
    Randomized trial58 participantsInflammation forCoenzyme Q-10
  20. Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.
    Mantle D; Hargreaves I · Antioxidants (Basel, Switzerland) · 2020
    Narrative reviewLongevity forCoenzyme Q-10